Team

Leadership Team

Seulki Lee, PhD
CEO

Dr. Lee, founder, is an expert in drug and protein delivery. His research is focused on identifying novel targets critically involved in the origination of the disease. He invented NLY01 and, in collaboration with Dr. Ted Dawson’s team, at John’s Hopkins School of Medicine, proved its exceptional neuroprotective activity in animal models of Parkinson’s disease and Alzheimer’s disease, which led to founding of Neuraly. Dr. Lee was Associate Professor of Radiology and Radiological Science at Johns Hopkins School of Medicine.

Viktor Roschke, PhD
CSO and Head of R&D

Dr. Roschke, co-founder, is Chief Scientific Officer and Head of Research and Development. He has more than 20 years of experience in drug development as senior executive in pharmaceutical and biotech companies such as Human Genome Sciences, Cogenesys, and Teva Pharmaceuticals.

Yen-Huei Lin, PhD VP, Technology Development and Manufacturing

Dr. Lin is a seasoned biotech executive with extensive expertise in biologics, synthetic modalities, and vaccines development. He has been instrumental in building development strategy and operations for Neuraly/D&D pipeline products. With over 20 years of experience at Novavax, Teva, Human Genome Sciences, and Wyeth, Dr. Lin contributed to the development and commercialization of innovative therapeutics and vaccines, such as NanoFlu, Ajovy, Cinqair, Balugrastim, Raxibacumab, Benlysta, Trumenba, and Prevnar.